Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin for Empirical Treatment of Suspected Invasive Candidiasis in ICU Patients
NCT01773876Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- Jul 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of micafungin in invasive candidiasis, sponsored by CHU Grenoble Alpes. Started Jul 2012; status: completed.
02
Drugs
micafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT01773876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01773876.